Product Images Zynrelef
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 86 images provide visual information about the product associated with Zynrelef NDC 47426-303 by Heron Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - zynrelef 01
Chemical Structure - zynrelef 02
Chemical Structure - zynrelef 03
Figure 1 - zynrelef 04
The text describes the NRS-A pain intensity score with mean and standard error for three different groups treated with ZYNRELEF, Bupivacaine HCI, and Saline Placebo respectively. The data is represented in a graph that shows the pain intensity score at different hours post-study drug administration.*
Figure 2 - zynrelef 05
Figure 3 - zynrelef 06
Figure - zynrelef 07
Figure - zynrelef 08
Figure - zynrelef 09
Figure - zynrelef 10
Figure - zynrelef 11
Figure - zynrelef 12
Figure - zynrelef 13
Figure - zynrelef 14
Figure - zynrelef 15
Figure - zynrelef 16
Figure - zynrelef 17
Figure - zynrelef 18
Figure - zynrelef 19
Figure - zynrelef 20
Figure - zynrelef 21
Figure - zynrelef 22
Figure - zynrelef 23
Figure - zynrelef 24
Figure - zynrelef 25
Figure - zynrelef 26
This text suggests that when assembling or replacing components, it is important not to use substitutes for any of the original parts. This is likely a safety precaution to ensure the proper functioning of the machine or device in question.*
Figure - zynrelef 27
Figure - zynrelef 28
Figure - zynrelef 29
Figure - zynrelef 30
Figure - zynrelef 31
Figure - zynrelef 32
Figure - zynrelef 33
Figure - zynrelef 34
Figure - zynrelef 35
Figure - zynrelef 36
Figure - zynrelef 37
Figure - zynrelef 38
Figure - zynrelef 39
Figure - zynrelef 40
Figure - zynrelef 41
Figure - zynrelef 42
Figure - zynrelef 43
Figure - zynrelef 44
Figure - zynrelef 45
This is a warning message advising not to replace any of the parts or components.*
Figure - zynrelef 46
Figure - zynrelef 47
Figure - zynrelef 48
Figure - zynrelef 49
Figure - zynrelef 50
Figure - zynrelef 51
Figure - zynrelef 52
Figure - zynrelef 53
Figure - zynrelef 54
Figure - zynrelef 55
Figure - zynrelef 56
Figure - zynrelef 57
Figure - zynrelef 58
Figure - zynrelef 59
Figure - zynrelef 60
Figure - zynrelef 61
Figure - zynrelef 62
Figure - zynrelef 63
Figure - zynrelef 64
This text is readable and the description would be: "This text provides a warning not to substitute any of the components."*
Figure - zynrelef 65
Figure - zynrelef 66
Figure - zynrelef 67
Figure - zynrelef 68
Figure - zynrelef 69
Figure - zynrelef 70
Figure - zynrelef 71
Figure - zynrelef 72
Figure - zynrelef 73
Figure - zynrelef 74
Figure - zynrelef 75
Figure - zynrelef 76
Figure - zynrelef 77
Figure - zynrelef 78
Figure - zynrelef 79
Figure - zynrelef 80
Figure - zynrelef 81
Figure - zynrelef 82
PRINCIPAL DISPLAY PANEL - 14 mL Vial Carton Kit - zynrelef 83
PRINCIPAL DISPLAY PANEL - 10.5 mL Vial Carton Kit - zynrelef 84
PRINCIPAL DISPLAY PANEL - 7 mL Vial Carton Kit - zynrelef 85
PRINCIPAL DISPLAY PANEL - 2.3 mL Vial Carton Kit - zynrelef 86
ZYNRELEF is a solution for soft tissue or periarticular instillation use that contains 50 mg bupivacaine and 1.8 mg meloxicam. This single-dose application package includes a 23 mL vial and sterile syringe with an Luer Lock, cap, and applicator. The kit must be used as instructed, and unused portion must be discarded. Storage instructions mandate storing the kit from 2°C to 25°C. This text also includes batch and manufacturing information, along with prescribing and dosage instruction warnings.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.